+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Inflammation Drug"

From
US Axial Spondyloarthritis Market outlook to 2028 - Product Thumbnail Image

US Axial Spondyloarthritis Market outlook to 2028

  • Report
  • October 2023
  • 85 Pages
  • United States
From
From
From
Corticosteroids Therapy Global Market Report 2023 - Product Thumbnail Image

Corticosteroids Therapy Global Market Report 2023

  • Report
  • February 2023
  • 175 Pages
  • Global
From
Neutropenia Biologic Drug Treatment Global Market Report 2024 - Product Thumbnail Image

Neutropenia Biologic Drug Treatment Global Market Report 2024

  • Report
  • February 2024
  • 250 Pages
  • Global
From
Psoriatic Arthritis Treatment Global Market Report 2024 - Product Thumbnail Image

Psoriatic Arthritis Treatment Global Market Report 2024

  • Report
  • February 2024
  • 250 Pages
  • Global
From
Hydroxychloroquine Global Market Report 2024 - Product Thumbnail Image

Hydroxychloroquine Global Market Report 2024

  • Report
  • February 2024
  • 250 Pages
  • Global
From
From
Research Report on China's Ibuprofen Export 2023-2032 - Product Thumbnail Image

Research Report on China's Ibuprofen Export 2023-2032

  • Report
  • January 2023
  • 50 Pages
  • China
From
Investigation Report on China's Diclofenac Market, 2019-2023 - Product Thumbnail Image

Investigation Report on China's Diclofenac Market, 2019-2023

  • Report
  • August 2019
  • 30 Pages
  • China
From
TRS01 Market Size, Forecast, and Emerging Insight - 2032 - Product Thumbnail Image

TRS01 Market Size, Forecast, and Emerging Insight - 2032

  • Report
  • February 2024
  • 30 Pages
  • Global
From
JAK inhibitors - Competitive Landscape, 2023 - Product Thumbnail Image

JAK inhibitors - Competitive Landscape, 2023

  • Report
  • April 2023
  • 180 Pages
  • Global
From
Psoriatic Arthritis - Epidemiology Forecast - 2032 - Product Thumbnail Image

Psoriatic Arthritis - Epidemiology Forecast - 2032

  • Report
  • September 2022
  • 141 Pages
  • Global
From
Loading Indicator

The Immune Disorders Drugs market is composed of drugs used to treat a variety of conditions related to the immune system. These drugs are used to treat autoimmune diseases, allergies, and other conditions that affect the body's ability to fight off infection. Inflammation drugs are a subset of these drugs, used to reduce inflammation and swelling caused by an immune response. These drugs can be used to treat a variety of conditions, including rheumatoid arthritis, psoriasis, and Crohn's disease. They can also be used to reduce the risk of infection in patients with weakened immune systems. Inflammation drugs are typically administered orally or intravenously, and can be taken as a single dose or as part of a longer-term treatment plan. Common side effects of these drugs include nausea, vomiting, and diarrhea. Companies in the Immune Disorders Drugs market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more